FDA MDR ENFORCEMENT ACTIONS: BEST PRACTICES FOR STRENGTHENING MEDWATCH FORM WRITING AND REPORTING

PRODUCT INFO

Includes 1 Hour Windows Media Video File and PowerPoint presentations for immediate download.

The EU and the UK recently reached an agreement on the Brexit transitional period, where EU law will continue to apply in the UK during the 21 month conversion. While this development was welcomed by many healthcare authorities and companies who will conduct business during and after the transition period, ambiguity remains regarding the UK’s future alignment with the EU regulatory framework and regulatory authorities. A thorough update on Brexit provisions specific to UK device research, development and marketing will be valuable to all device companies operating in the UK.

  • Brexit updates and timelines for CE-marked devices
  • Defining new roles of key stakeholders:
    • Manufacturer
    • Authorized Representative
    • Notified Body
  • Transition strategies with key action items for planning
  • Brexit and the new EU Medical Devices Regulation

Speakers:
Eveline Van Keymeulen
Counsel
Allen & Overy LLP

Jacqueline Bore
Life Sciences PSL
Allen & Overy LLP

Contact:

Brooke Akins | Manager, Market Intelligence | 312.224.1693 webinars@q1productions.com

CONTACT US
Q1 Productions
500 N. Dearborn Suite 500 | Chicago, IL 60654
Chicago, IL 60654
T: 312.822.8100
F: 312.873.3969
marketing@q1productions.com

Share This